MOUNJARO 7.5mg KwikPen, 1 Stk.
$519.00
| Quantity | Discount (%) | Price |
|---|---|---|
| 1 - 5 | — | $519.00 |
| 6 - 10 | 11.56 % | $459.00 |
| 11 - 20 | 12.52 % | $454.00 |
| 21+ | 13.49 % | $449.00 |
MOUNJARO® 7.5mg KwikPen® is a multi-dose, pre-filled injection device delivering 7.5 mg tirzepatide in 0.6 mL once weekly via subcutaneous injection. It is used for the treatment of adults with type 2 diabetes mellitus and as an adjunct for weight management in patients who meet clinical BMI thresholds. Each KwikPen® contains 2.4 mL of solution (total of 30 mg tirzepatide) and supplies four fixed doses. The solution is a clear, colourless to slightly yellow liquid, administered in the abdomen, thigh, or upper arm


